0001209191-15-083423.txt : 20151203
0001209191-15-083423.hdr.sgml : 20151203
20151203210529
ACCESSION NUMBER: 0001209191-15-083423
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151201
FILED AS OF DATE: 20151203
DATE AS OF CHANGE: 20151203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ULLIAN ELAINE
CENTRAL INDEX KEY: 0001190290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151268713
MAIL ADDRESS:
STREET 1: C/O HOLOGIC, INC.
CITY: BEDFORD
STATE: MA
ZIP: 01730
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-12-01
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001190290
ULLIAN ELAINE
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-12-01
4
M
0
22500
59.55
A
27765
D
Common Stock
2015-12-01
4
S
0
6289
128.78
D
21476
D
Common Stock
2015-12-01
4
S
0
10711
129.77
D
10765
D
Common Stock
2015-12-01
4
S
0
5400
130.68
D
5365
D
Common Stock
2015-12-01
4
S
0
100
131.38
D
5265
D
Stock Option (right to buy)
59.55
2015-12-01
4
M
0
22500
0.00
D
2022-05-31
Common Stock
22500
0
D
Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $128.78 (range $128.25 to $129.23).
Ms. Ullian undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $129.77 (range $129.25 to $130.24).
Open market sales reported on this line occurred at a weighted average price of $130.68 (range $130.26 to $131.25).
Fully vested.
Omar White, Attorney-In-Fact
2015-12-03